Skip to main content
Article thumbnail
Location of Repository

Glucocorticoid receptor interacting protein-1 restores glococorticoid responsiveness in steroid-resistant airway structural cells

By Reena Bhandare, Gautam Damera, Audreesh Banerjee, Jamie R. Flammer, Stefan Keslacy, Inez Rogatsky, Reynold A. Panettieri, Yassine Amrani and Omar Tliba

Abstract

Glucocorticoid (GC) insensitivity represents a profound challenge in managing patients with asthma. The mutual inhibition of transcriptional activity between GC receptor (GR) and other regulators is one of the mechanisms contributing to GC resistance in asthma. We recently reported that interferon regulatory factor (IRF)-1 is a novel transcription factor that promotes GC insensitivity in human airway smooth muscle (ASM) cells by interfering with GR signaling (Tliba et al., Am J Respir Cell Mol Biol 2008;38:463–472). Here, we sought to determine whether the inhibition of GR function by IRF-1 involves its interaction with the transcriptional co-regulator GR-interacting protein 1 (GRIP-1), a known GR transcriptional co-activator. We here found that siRNA-mediated GRIP-1 depletion attenuated IRF-1–dependent transcription of the luciferase reporter construct and the mRNA expression of an IRF-1–dependent gene, CD38. In parallel experiments, GRIP-1 silencing significantly reduced GR-mediated transactivation activities. Co-immunoprecipitation and GST pull-down assays showed that GRIP-1, through its repression domain, physically interacts with IRF-1 identifying GRIP-1 as a bona fide transcriptional co-activator for IRF-1. Interestingly, the previously reported inhibition of GR-mediated transactivation activities by either TNF- and IFN- treatment or IRF-1 overexpression was fully reversed by increasing cellular levels of GRIP-1. Together, these data suggest that the cellular accumulation of IRF-1 may represent a potential molecular mechanism mediating altered cellular response to GC through the depletion of GRIP-1 from the GR transcriptional regulatory complexes

Topics: glucocorticoid, cytokine, airway smooth muscle, IRF-1, GRIP-1
Publisher: American Thoracic Society
Year: 2009
DOI identifier: 10.1165/rcmb.2009-0239RC
OAI identifier: oai:lra.le.ac.uk:2381/8109
Journal:

Suggested articles

Citations

  1. (1998). 352 Structure and specificity of nuclear receptor-coactivator interactions. Genes Dev doi
  2. (2008). Dual ERK and 341 phosphatidylinositol 3-kinase pathways control airway smooth muscle proliferation: 342 differences in asthma. doi
  3. (2004). Fractalkine/CX3CL1 345 production by human airway smooth muscle cells: induction by IFN-gamma and TNF-346 alpha and regulation by TGF-beta and corticosteroids. doi
  4. (2002). The function of 355 TIF2/GRIP1 in mouse reproduction is distinct from those of SRC-1 and p/CIP. doi
  5. (2000). The SRC family of nuclear receptor coactivators. Gene doi
  6. (2000). The steroid receptor coactivator, 349 GRIP-1, is necessary for MEF-2C-dependent gene expression and skeletal muscle 350 differentiation. Genes Dev

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.